Status:
COMPLETED
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Innovex, Inc
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
17+ years
Brief Summary
The purpose of the study is to determine the long term safety of Enbrel in adults with active rheumatoid arthritis in Luxemburg. This is a post-marketing surveillance study in rheumatology practice pa...
Eligibility Criteria
Inclusion
- Have moderate to severe active rheumatoid arthritis
- Be aged of 17 years or more
- Have inadequate response to DMards
- Give written informed consent
- Physician decides to prescribe Enbrel
Exclusion
- n/a
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00195338
Start Date
May 1 2004
End Date
December 1 2010
Last Update
January 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Luxembourg, Luxembourg, L-2420